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Mortality in older children and adolescents: the forgotten ones
What happens in childhood has profound implications for 
adult life and for national development. Conven tionally, 
particularly in the Millennium Development Goals era, 
attention on child health focused on under-5 mortality. 
Globally, under-5 mortality declined by 55% between 
1990 and 2016, with Europe being one of the few regions 
exceeding a 70% decline.1 But gains in under-5 mortality 
have not been consolidated in later childhood. Globally, 
the decline in mortality in children aged 5–14 years has 
been a more modest 44%, corresponding to an estimated 
mean of about 1 million (95% CI 0·9–1·1 million) deaths 
in 2016.1 Thus, the continuing mortality burden in 
children aged 5–14 years in all regions of the world makes 
the detailed estimates of cause-specific mortality in this 
age group for the WHO European Region by Hmwe Kyu 
and colleagues2 particularly welcome.
Recognition has been increasing of the fact that, 
although the first 1000 days of life are crucial, the 
subsequent 7000 days have a pivotal role in individual 
development and attainment of healthy adulthood. The 
World Bank’s third edition of Disease Control Priorities 
in 2017 gave particular attention to child and adolescent 
health.3 The report particularly notes that the narrow 
focus on the first 1000 days “has not only resulted in a 
neglect of health services provision”, but “also deflected 
research away” from older children (aged 5–9 years) and 
younger adolescents (aged 10–14 years). Analyses of 
cause-specific morbidity and mortality in this age group 
are generally sporadic, and the estimates by Kyu and 
colleagues2 are therefore valuable. The primary purpose 
of these estimates should be to inform policy makers 
and other health actors to develop targeted intervention 
policies. Thus, the guiding principles for any such 
analysis would be what (are the leading causes), where 
(are deaths occurring), and who (is at risk)?
Globally, although communicable diseases continue 
to be the largest single contributor to mortality, non-
communicable diseases and injuries together contribute 
about half of the mortality in people aged 5–14 years.1 
GBD online estimates suggest that communicable 
diseases caused 69% of deaths in this age group during 
2015 in the WHO African Region, accounting for most of 
the greater all-cause mortality in that region, in contrast 
to the rest of the world. Injuries were the leading cause 
of deaths in children aged 5–14 years in all other WHO 
Regions apart from the European Region, wher, by 2016, 
non-communicable diseases are the largest contributor 
(44% of deaths). In the European Region, communicable 
diseases (particularly lower respiratory infections) were 
the leading cause of deaths only in the Commonwealth 
of Independent States (CIS).2 A recent analysis of injury-
related deaths among children younger than 15 years in 
Europe reported that, in 2015, the leading specific causes 
were drowning and road traffic accidents.4 The analysis 
reported a wide disparity in mortality rates for all injuries 
and unintentional injuries when analysed by World Bank 
income regions (a six-times difference between high-
income countries vs low-income and middle-income 
countries); for some specific causes, the differences 
were greater, including drowning (nine times), falls 
(ten times), and poisonings (12 times). The analysis by 
Kyu and colleagues2 similarly highlights the stark contrast 
between the most developed countries (EU15) and the 
least developed countries (CIS) in the WHO European 
Region, including a four-times difference in mortality 
rates from road traffic accidents and a 14-times difference 
from drowning.2 The appendix of Kyu and colleagues’ 
paper and other studies4,5 show disparities between the 
sexes for some causes, although not necessarily agreeing 
on the rates or direction of change. An analysis of linked 
routine data in the UK reported that self-harm (which is 
the sixth leading cause of death in Europe in 10–14 year 
olds) is not only three-times higher in girls than boys, but 
showed a sharp 68% increase between 2000 and 2015.5 
By contrast, Kyu and colleagues2 do not report any sex 
differences in the rates of self-harm across the UK, and in 
fact, report a 33% decrease in the number of cases of self-
harm in the corresponding period.
The vast majority of deaths in people aged 5–14 years 
are preventable, not only in Europe but also globally. 
GBD analyses generally have been extremely influential 
in highlighting the cause-specific burden of morbidity 
and mortality in various age groups. Therefore, similar 
global and regional analyses for the 5–14 years age 
group based on the GBD estimates, including sex-
disaggregated data for this age group that includes 
sex-divergent biological and behavioural risks during 
puberty, would undoubtedly be helpful in creating and 
raising awareness for child and adolescent health among 
policy makers and funders. These analyses should lead to 
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The influenza virus causes infections in all age groups, 
and disease severity is greatest in young children and 
older adults. In children younger than 5 years, influenza is 
associated with an average of 100 000 respiratory deaths1 
and as many as 1 million hospital admissions annually.2 
Notwithstanding those statistics, most influenza virus 
infections in children are mild and self-limiting.
A wealth of evidence supports the efficacy of 
inactivated influenza vaccines in children aged 
3–16 years.3 Far fewer trials have been done in young 
children younger than 2 years.3 In one controlled trial 
in Bangladesh, which included 4081 children aged 
6–23 months, the efficacy of trivalent inactivated 
influenza vaccine was estimated to be 31% (95% CI 
18–42%) against PCR-confirmed influenza.4 In The Lancet 
Child & Adolescent Health, Carine Claeys and colleagues5 
present findings from a randomised trial in which 6006 
children received a quadrivalent inactivated influenza 
vaccine (IIV4) and 6012 children received a control 
vaccine. 11 404 children (5707 children in the IIV4 group 
and 5697 children in the control group) were included 
in the primary per-protocol analysis of vaccine efficacy 
against PCR-confirmed influenza across five influenza 
seasons, and the estimated vaccine efficacy was 63% 
(95% CI 52–72%) against moderate-to-severe influenza 
and 50% (42–57%) against all influenza.5 
We agree with the authors that protection against 
severe influenza necessitating hospital admission is of 
greatest clinical and public health importance. However, 
as stated by the authors, hospital admissions were not 
common, and protection against severe influenza was 
not documented in this study. Only five children met 
the criteria for severe influenza, and more than half of 
the children with moderate-to-severe influenza had 
fever (>39°C) as the condition meeting the criteria for 
moderate influenza.
One notable observation was the moderate vaccine 
efficacy against influenza A(H3N2) and the high efficacy 
against influenza B/Victoria, despite most isolates from 
participating children being antigenically mismatched 
with the vaccine strains.5 As noted by Claeys and 
colleagues, other investigators have also found good 
vaccine efficacy and effectiveness against mismatched 
strains in young children. We would encourage a follow-
up analysis to examine vaccine efficacy against matched or 
mismatched strains separately and that the investigators 
describe the degree of mismatch in more detail.
The mean follow-up period of each participant was 
only 4 months.5 More than 70% of children in this study 
were recruited from countries with subtropical climates 
where influenza circulation is known to be prolonged or 
even last year round.6 Whether or not annual vaccination 
can provide year-round protection in these locations 
should be confirmed.
Claeys and colleagues made the important obser-
vation that the relative risk of antibiotic use in children 
improved provision of health care (targeted at the most 
vulnerable populations) and a will to enact appropriate 
risk reduction and legislation (eg, health and safety, 
smoke-free environments, and flour fortification), 
thereby enabling children and adolescents to attain their 
maximum potential.
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